Head and neck cancer: Identifying markers to facilitate better treatment in the future

byMedical University of ViennaCredit: AI-generated imageMalignant tumors in the head and neck region are very heterogeneous and therefore difficult to treat. In addition, the lack of prognostic

Updated on: January 07,2024

Head and neck cancer: Identifying markers to facilitate better treatment in the future

byMedical University of ViennaCredit: AI-generated imageMalignant tumors in the head and neck region are very heterogeneous and therefore difficult to treat. In addition, the lack of prognostic

Updated on:January 07,2024

Current PSA monitoring ignores risk to some prostate cancer survivors

by Scott Maier,University of California, San FranciscoCredit: University of California, San FranciscoProstate cancer survivors make up the largest group, 41 percent, of male cancer survivors. In

Updated on: March 09,2024

Current PSA monitoring ignores risk to some prostate cancer survivors

by Scott Maier,University of California, San FranciscoCredit: University of California, San FranciscoProstate cancer survivors make up the largest group, 41 percent, of male cancer survivors. In

Updated on:March 09,2024

A way to prevent pancreatic cancer from spreading post-surgery?

by Cold Spring Harbor LaboratoryOn the left is a section of a pancreatic cancer patient's primary tumor, with cancer cells (red) and CK19, a marker of proliferation (green), evident. On the r

Updated on: May 05,2024

A way to prevent pancreatic cancer from spreading post-surgery?

by Cold Spring Harbor LaboratoryOn the left is a section of a pancreatic cancer patient's primary tumor, with cancer cells (red) and CK19, a marker of proliferation (green), evident. On the r

Updated on:May 05,2024

Determinants of overall survival in metastatic uveal melanoma identified

by Elana GotkineFactors associated with improved survival in metastatic uveal melanoma include female sex and use of anti‐cytotoxic T lymphocyte-associated antigen (CTLA)‐4 and anti‐programmed cell de

Updated on: January 22,2024

Determinants of overall survival in metastatic uveal melanoma identified

by Elana GotkineFactors associated with improved survival in metastatic uveal melanoma include female sex and use of anti‐cytotoxic T lymphocyte-associated antigen (CTLA)‐4 and anti‐programmed cell de

Updated on:January 22,2024

Repurposing FDA-approved drugs can help fight back breast cancer

by Baylor College of MedicineMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/WikipediaScreening Food and Dr

Updated on: April 07,2024

Repurposing FDA-approved drugs can help fight back breast cancer

by Baylor College of MedicineMicrograph showing a lymph node invaded by ductal breast carcinoma, with extension of the tumour beyond the lymph node. Credit: Nephron/WikipediaScreening Food and Dr

Updated on:April 07,2024

Team discovers gene mutations linked to pancreatic cancer

by Susan Buckles,Mayo ClinicCredit: Mayo ClinicSix genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's acc

Updated on: May 27,2024

Team discovers gene mutations linked to pancreatic cancer

by Susan Buckles,Mayo ClinicCredit: Mayo ClinicSix genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's acc

Updated on:May 27,2024

Doctors and molecular engineers working to enlist the immune system to fight cancer

by Sharla A. Paul,University of ChicagoT cells attacking cancer. Credit: royaltystockphotoWhen telling the story of immunotherapy and cancer and how the two battle it out, it's awfully chall

Updated on: May 17,2024

Doctors and molecular engineers working to enlist the immune system to fight cancer

by Sharla A. Paul,University of ChicagoT cells attacking cancer. Credit: royaltystockphotoWhen telling the story of immunotherapy and cancer and how the two battle it out, it's awfully chall

Updated on:May 17,2024

Altered cell behavior behind resistance in neuroblastoma

byLund UniversityEstablishment and application of a COJEC-like treatment protocol using NB PDX models.(A) Schematic representation of the experimental design. Mice were injected subcutaneously (

Updated on: January 04,2024

Altered cell behavior behind resistance in neuroblastoma

byLund UniversityEstablishment and application of a COJEC-like treatment protocol using NB PDX models.(A) Schematic representation of the experimental design. Mice were injected subcutaneously (

Updated on:January 04,2024

Re-engineering cancerous tumors to self-destruct and kill drug-resistant cells

byPennsylvania State UniversityCredit: Unsplash/CC0 Public DomainTreating cancer can sometimes feel like a game of Whac-A-Mole. The disease can become resistant to treatment, and clinicians neve

Updated on: July 05,2024

Re-engineering cancerous tumors to self-destruct and kill drug-resistant cells

byPennsylvania State UniversityCredit: Unsplash/CC0 Public DomainTreating cancer can sometimes feel like a game of Whac-A-Mole. The disease can become resistant to treatment, and clinicians neve

Updated on:July 05,2024

New major survey finds 'healthy' suntan myths persist despite warnings about skin cancer and aging

by European Academy of Dermatology and VenereologyCredit: CC0 Public DomainAmong Europeans, 8 in 10 believe tans are attractive, with almost as many (73%) saying tans are healthy, according to a new s

Updated on: February 01,2024

New major survey finds 'healthy' suntan myths persist despite warnings about skin cancer and aging

by European Academy of Dermatology and VenereologyCredit: CC0 Public DomainAmong Europeans, 8 in 10 believe tans are attractive, with almost as many (73%) saying tans are healthy, according to a new s

Updated on:February 01,2024

Phase 1 study: New medicine extends terminally-ill cancer patients' lives

by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague

Updated on: February 18,2024

Phase 1 study: New medicine extends terminally-ill cancer patients' lives

by Norwegian University of Science and TechnologyMarit Otterlei (center) is a professor at the Norwegian University of Science and Technology. A new cancer drug developed by her and her colleague

Updated on:February 18,2024

Team develops tools and techniques to explore cancer signals at the subcellular level

by Jerry Grillo,Georgia Institute of TechnologyGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104980This year, about 240,000 people in the U.S. will discover the

Updated on: January 08,2024

Team develops tools and techniques to explore cancer signals at the subcellular level

by Jerry Grillo,Georgia Institute of TechnologyGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.104980This year, about 240,000 people in the U.S. will discover the

Updated on:January 08,2024